[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338726-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338726-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ex-vivo-microscopic-testicular-sperm-extraction-at-the-time-of-radical-orchiectomy-in-men-with-nonobstructive-azoospermia-noa-a-scoping-review","Ex vivo microscopic testicular sperm extraction at the time of radical orchiectomy in men with nonobstructive azoospermia (NOA): a scoping review","","Testicular tumors can impair male fertility by damaging surrounding healthy tissue and may contribute to nonobstructive azoospermia (NOA), a severe form of infertility. In oncologic care, testicular sperm retrieval is often performed before gonadotoxic therapies, using techniques such as oncological TESE and microdissection testicular sperm extraction. This invited review evaluates ex vivo microscopic mTESE performed at radical orchiectomy, summarizes literature search methods and inclusion criteria, identifies tumor size as a key preoperative factor, and reports satisfactory retrieval success and live-birth outcomes via assisted reproduction.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ex-vivo-microscopic-testicular-sperm-extraction-at-the-time-of-radical-orchiectomy-in-men-with-nonobstructive-azoospermia-noa-a-scoping-review/338726/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ex-vivo-microscopic-testicular-sperm-extraction-at-the-time-of-radical-orchiectomy-in-men-with-nonobstructive-azoospermia-noa-a-scoping-review/338726.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the objective of this review?","Question",{"text":63,"@type":64},"To review the literature on outcomes of oncological (Onco)-mTESE performed at the time of radical orchiectomy in men with testicular tumor-related infertility and NOA.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which preoperative factor was identified as influencing spermatogenesis?",{"text":68,"@type":64},"Tumor size was identified as the sole preoperative factor influencing spermatogenesis.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the review describe evidence comparing Onco-mTESE with conventional Onco-TESE?",{"text":72,"@type":64},"No comparison between Onco-mTESE and conventional Onco-TESE has been made, and further assessment is required.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338726,1790582915,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826","Asian Journal of Andrology (2025) 27, 416–422 [www.asiaandro.com](www.asiaandro.com); [https://journals.lww.com/ajandrology](https://journals.lww.com/ajandrology)  \nOpen Access  \nAssisted Reproductive Technology  \nINVITED REVIEW  \nEx vivo microscopic testicular sperm extraction at the time of radical orchiectomy in men with nonobstructive azoospermia (NOA): a scoping review  \nCarlo Giulioni1,2, Nguyen Ho Vinh Phuoc2,3, Selahittin Cayan2,4  \nTesticular tumor is the most common solid malignancy in males under 40 years of age. This malignancy is known to have a negative impact on male fertility. Therefore, several techniques for sperm retrieval have been proposed, including microdissection testicular sperm extraction (mTESE) . The objective of this study was to review the literature on the outcomes of oncological (Onco)-mTESE atthe time of radical orchiectomy. We conducted a comprehensive literature search through PubMed, Scopus, and Cochrane Central Controlled Register of Trials. Only studies reporting ex vivo mTESE in patients with testicular tumor were considered. Twelve papers met the inclusion criteria and were included in this review. Tumor size was identified as the sole preoperative factor influencing spermatogenesis. The considered studies demonstrated a satisfactory success rate for Onco-mTESE, associated with a similarly valid percentage of live healthy births through assisted reproductive technology. Currently, no comparison has been made between Onco-mTESE and conventional Onco-TESE, hence further assessment is required. In cases where the tumor completely replaces the cancer-bearing testicle, a contralateral micro-TESE may be a viable alternative. However, the surgeon should evaluate associated risksand benefits preoperatively. In conclusion, Onco-mTESE at the time of radical orchiectomy appears to be a promising therapeutic option for young patients with testicular tumors. Nevertheless, additional studies are necessary to achieve a definitive conclusion. Asian Journal of Andrology (2025) 27 , 416–422; doi: 10.4103/aja202387; published online: 06 February 2024  \nKeywords: assisted reproductive technology; ex vivo; microdissection testicular sperm extraction; radical orchiectomy; testicular tumor  \nINTRODUCTION  \nTesticular tumors (TTs) are a relatively uncommon form of cancer in males, accounting for approximately 1%–3% of all male malignancies.1 They are the most prevalent nonhematologic malignancy among males aged 15 years to 49 years. Globally, an estimated 74 500 cases of testicular tumors were reported in 2020.2 The majority of these tumors (approximately 95%) are germ cell tumors (GCTs) . TTs have the potential to negatively impact fertility due to their harmful effects on the surrounding healthy tissue, leading to a significant reduction in sperm production. Several factors, such as bilateral TT, germ cell neoplasia in situ (GCNIS), advanced tumor stage, smaller testes, Sertoli cell-only (SCO) syndrome, and a history of undescended testicles (UDTs), can directly affect spermatogenesis.3 More than half of the patients with testicular cancer at diagnosis exhibit low sperm count (oligozoospermia), while up to 24% may experience the absence of sperm in the ejaculate (azoospermia) .4 The inherent risk of reduced fertility, combined with the potential for treatment-induced infertility, which can be permanent, is a major concern. Testicular cancer patients experience an average decline of 30% in fertility.5 Consequently, thereis a significant need to predict and effectively address the infertility issues faced by these individuals. Over time, this condition can progress to nonobstructive azoospermia (NOA), which is considered the most severe form of male infertility. However, individuals with  \nNOA may still have viable sperm present in their testicles.6 Therefore, assisted reproductive techniques, including percutaneous and open surgical procedures, are available to retrieve sperm in cases of NOA.7 Intracytoplasmic","cbCaiiC9172wVcGy","https://ap.wps.com/l/cbCaiiC9172wVcGy","pdf",310938,"English","# Introduction\n## Testicular tumors and fertility impact\n## Progression to nonobstructive azoospermia (NOA)\n## Sperm retrieval and assisted reproduction in NOA\n# Oncological context and rationale\n## Onco-TESE before chemotherapy or radiotherapy\n## Timing with radical orchiectomy\n# Review approach and included studies\n## Literature search strategy and inclusion criteria\n## Reported outcomes and preoperative factors\n# Conclusions and clinical implications\n## Promising therapeutic option and need for further studies","[{\"question\":\"What is the objective of this review?\",\"answer\":\"To review the literature on outcomes of oncological (Onco)-mTESE performed at the time of radical orchiectomy in men with testicular tumor-related infertility and NOA.\"},{\"question\":\"Which preoperative factor was identified as influencing spermatogenesis?\",\"answer\":\"Tumor size was identified as the sole preoperative factor influencing spermatogenesis.\"},{\"question\":\"How does the review describe evidence comparing Onco-mTESE with conventional Onco-TESE?\",\"answer\":\"No comparison between Onco-mTESE and conventional Onco-TESE has been made, and further assessment is required.\"}]","Ex vivo microscopic testicular sperm extraction at the time of radical orchiectomy in men with nonobstructive azoospermia (NOA): a scoping review | PDF",1790025304,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/439f4d9ca26f7703d352f65a0a49d9c9.webp",983,1287,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c95db20b738acd786bc8a2551b37cf1c.webp",982,1286,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7db2d840b175cabc78125739fc3ffa6.webp",981,1284,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f4ca174ed0e1fd269421720eacd9e824.webp",980,1283]